Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-029576
Filing Date
2023-03-07
Accepted
2023-03-07 16:23:25
Documents
5
Effectiveness Date
2023-03-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm238716d1_s8.htm S-8 45903
2 EXHIBIT 5.1 tm238716d1_ex5-1.htm EX-5.1 8879
3 EXHIBIT 23.1 tm238716d1_ex23-1.htm EX-23.1 2117
4 EX-FILING FEES tm238716d1_exfilingfees.htm EX-FILING FEES 13488
5 GRAPHIC tm238716d1_ex5-1img001.jpg GRAPHIC 2544
  Complete submission text file 0001104659-23-029576.txt   75019
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270329 | Film No.: 23712928
SIC: 2834 Pharmaceutical Preparations